Medication info
Pharma Empagliflozin Metformin Duo Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Pharma Empagliflozin Metformin Duo Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
Biconvex oval film-coated tablets with a light brownish purple color
Packaging
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202302644 · Approved 2023.09.05 · Insurance code 653007080

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood sugar control abnormalities
  • type 2 diabetes
  • cardiovascular disease
View approved original text

This medication is used in conjunction with dietary control and exercise therapy to help patients with type 2 diabetes manage their blood sugar levels. It is particularly suitable for patients whose blood sugar levels are not adequately controlled, and caution should be exercised for those with cardiovascular diseases. For detailed information related to the occurrence of cardiovascular events, it is recommended to refer to clinical trial data for professionals. This medication helps improve blood sugar control and assists in diabetes management.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication consists of two components that help lower blood sugar levels. Caution is advised as a rare side effect of serious lactic acidosis may occur when taking this medication. Lactic acidosis can lead to excessive accumulation of lactic acid in the body, causing serious health issues that can occasionally be life-threatening. Additionally, when used in conjunction with insulin or other diabetes medications, hypoglycemia may occur, so symptoms should be closely monitored. Patients with poor kidney function, acute kidney problems, serious infections, or heart failure should not use this medication. It should especially not be administered to patients with moderate to severe renal impairment. If iodine contrast agents are administered during radiologic examinations, this medication should be discontinued before and after the test, and resuming use should only occur once normal kidney function is confirmed. It is safer for women who are pregnant, may become pregnant, or are nursing to avoid taking this medication. This medication should be taken with regular monitoring of kidney function, and if dehydration or severe vomiting, diarrhea, etc., occur, it is advisable to temporarily discontinue use. While taking this medication, side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, taste disorders, itching, rash, erythema, angioedema, dysuria, thirst, increased serum lipids, increased serum creatinine, increased hematocrit, decreased and deficiency of vitamin B12, decreased fluid volume, headache, dizziness, drowsiness, insomnia, hypertension, fatigue, weakness, facial edema, and weight changes may occur, and if any unusual symptoms appear, immediate consultation with healthcare professionals is essential. Elderly patients or those at risk of fluid loss should take extra caution when using this medication, and regular monitoring of vitamin B12 levels is recommended. Excessive alcohol consumption should be avoided, and alcoholic beverages should be refrained from while taking this medication. If surgery is planned, this medication should be discontinued 48 hours prior to the surgery, and after ensuring normal kidney function postoperative, it can be resumed. During the course of this medication, blood sugar levels should be frequently checked, and dosage adjustments may be necessary when used in conjunction with other medications that pose a risk of hypoglycemia. This medication is not recommended for children or adolescents under 18 years of age, and elderly patients require dosage adjustments and regular monitoring based on renal function. In cases of overdose, seek medical attention immediately for appropriate treatment, and prompt treatment is required for lactic acidosis. Finally, this medication should be kept out of reach of children and stored in the original container to maintain its quality.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased vitamin B12 and deficiency
  • ketoacidosis
  • lactic acidosis
  • nausea
  • vomiting
  • diarrhea
Show 128 more
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • dysgeusia
  • itching
  • rash
  • urticaria
  • erythema multiforme
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased serum creatinine
  • decreased glomerular filtration rate
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • chronic gastritis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disorder
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • sensory impairment
  • orthostatic dizziness
  • dizziness
  • cerebral infarction
  • facial paralysis
  • drowsiness
  • weakness
  • chest discomfort
  • chest pain
  • fever
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight loss
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • double vision
  • hypertension
  • myocardial infarction
  • insomnia
  • anxiety
  • depression
  • sleep disorders
  • ear pain
  • orthostatic vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystal
  • retinal vein occlusion
  • serous retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • rib fracture
  • iliolumbar ligament syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • unstable angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, preferably at room temperature between 1 degree and 30 degrees Celsius. Storing it this way can help maintain its efficacy for a longer duration.

Appearance and packaging

Appearance

Biconvex oval film-coated tablets with a light brownish purple color

Package unit

60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.